DosePeer: GLP-1 Tracker

Konveria

About this app

DosePeer is a private tracker for people using GLP-1 medication (such as
semaglutide or tirzepatide) — plus an optional, anonymized look at structured
experiences other users chose to share.

Useful from day one, even with zero other users: your tracker, journal and
trends work fully on their own.

WHAT YOU CAN DO
• Track every injection — dose, date and body site, with a simple rotation map
• Follow your plan and titration, with on-device reminders for the next dose
• Log how you feel in a 30-second daily check-in (nausea, appetite, side effects)
• Record weight and optional body metrics, and see your trends over time
• Track your pen supply and expiry

WHAT OTHERS REPORTED (optional, opt-in)
Contribute a short structured survey and unlock aggregate statistics — “X% at
this dose reported Y” — always shown with the sample size, never anecdotes.
It is structured, quantified data from people who chose to share, not a forum
and not a comment section. You can opt in or withdraw at any time.

PRIVATE BY DESIGN
• Your journal is end-to-end encrypted on your device (AES-256). We store
ciphertext we cannot read.
• No ads. No AI on your data. We never sell raw data.
• The community pool is separate, explicit opt-in, and pseudonymized — cut off
from your account identity.
• Hosted in the EU. Built to GDPR standards. Export or delete your data anytime.

IMPORTANT
DosePeer is a wellness and tracking tool. The information it shows is
descriptive (for example, “a percentage of users reported an effect”) and is
NOT medical advice, diagnosis or treatment, and DosePeer is not a medical
device. Always consult a qualified clinician about your medication, dose or
symptoms. Never start, stop or change your dosing based on this app.

For adults (18+).

What’s new

Welcome to DosePeer — your private GLP-1 tracker.
• Log doses, side effects and weight; follow your plan with reminders
• Track injection sites and pen supply
• Optional, opt-in: structured, anonymised data on what others reported
Your journal is end-to-end encrypted on your device. No ads, no AI, no data selling.
Descriptive data, not medical advice.